Serial brain natriuretic peptides track change in 6 minute walk distance in pulmonary arterial hypertension

C. Carlin, K. Blyth, L. McLure, R. Spooner, A. Peacock, M. Johnson (Glasgow, United Kingdom)

Source: Annual Congress 2007 - Pulmonary hypertension in the clinic
Session: Pulmonary hypertension in the clinic
Session type: Electronic Poster Discussion
Number: 3286
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Carlin, K. Blyth, L. McLure, R. Spooner, A. Peacock, M. Johnson (Glasgow, United Kingdom). Serial brain natriuretic peptides track change in 6 minute walk distance in pulmonary arterial hypertension. Eur Respir J 2007; 30: Suppl. 51, 3286

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Stroke volume reflects changes in six minute walk test during follow-up in pulmonary arterial hypertension
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009

Can brain natriuretic peptide (BNP) be a predictor for pulmonary arterial hypertension?
Source: Annual Congress 2007 - Pulmonary hypertension: diagnosis and treatment
Year: 2007



Incapacity to increase pulmonary blood flow determines 6 minutes walking distance in pulmonary hypertension
Source: Annual Congress 2011 - Physiology of human pulmonary hypertension
Year: 2011

Cardiopulmonary exercise test unveils abnormal exercise physiology in patients affected by pulmonary arterial hypertension with a low-risk profile 6 minute walk distance.
Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension
Year: 2020


Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension
Source: Eur Respir J 2004; 24: Suppl. 48, 111s
Year: 2004

The 6-minute walk test adjusted for peak heart rate correlates with stroke volume index in pulmonary arterial hypertension
Source: Annual Congress 2004 - Pulmonary hypertension
Year: 2004


N-terminal-pro-brain natriuretic peptide as a haemodynamic marker in idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2005; 25: 509-513
Year: 2005



Connection of traditional echocardiographic and tissue doppler imaging parameters and brain natriuretic peptide levels in patients with different forms of pulmonary hypertension
Source: Annual Congress 2009 - Pulmonary hypertension
Year: 2009

Comparison of pulse oximetry and capillary blood gases pre and post six minute walk tests in healthy volunteers and patients with pulmonary arterial hypertension (PAH)
Source: Eur Respir J 2006; 28: Suppl. 50, 727s
Year: 2006

The role of per cent predicted 6-min walk distance in pulmonary arterial hypertension
Source: Eur Respir J 2010; 36: 1294-1301
Year: 2010



Cardiac function during exercise in pulmonary arterial hypertension
Source: Annual Congress 2005 - Exercise in pulmonary hypertension
Year: 2005


NT-proBNP reflects right ventricular structure and function in pulmonary hypertension
Source: Eur Respir J 2006; 28: 1190-1194
Year: 2006



Maximal cardiopulmonary exercise testing in mildly symptomatic patients with idiopathic pulmonary arterial hypertension: correlations with 6-min walk distance and resting hemodynamics
Source: Annual Congress 2009 - Pulmonary vascular diseases
Year: 2009

N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism
Source: Eur Respir J 2003 Oct 01;22(4):649-653
Year: 2003



Mean pulmonary artery pressure-heart rate (mPAP-HR) relationship during submaximal supine exercise in idiopathic pulmonary arterial hypertension (iPAH)
Source: Annual Congress 2005 - Exercise in pulmonary hypertension
Year: 2005


Heart rate responses during the 6-minute walk test in pulmonary arterial hypertension
Source: Eur Respir J 2006; 27: 114-120
Year: 2006



6 minute walk work and other clinical correlates of peak VO2 in pulmonary vascular disease
Source: International Congress 2019 – Pulmonary arterial hypertension: recent advances from the bedside
Year: 2019


NT-proBNP can be used to detect right ventricular systolic dysfunction in pulmonary hypertension
Source: Eur Respir J 2007; 29: 737-744
Year: 2007



Sequential analysis of right ventricular function and exercise capacity in pulmonary arterial hypertension
Source: International Congress 2019 – Pulmonary arterial hypertension: recent advances from the bedside
Year: 2019